RSS-Feed abonnieren
DOI: 10.1055/s-0028-1087970
Parallel Synthesis of Drug-like 5-Amino-Substituted 1,2,4-Thiadiazole Libraries Using Cyclization Reactions of a Carboxamidine Dithiocarbamate Linker
Publikationsverlauf
Publikationsdatum:
24. Februar 2009 (online)

Abstract
A general method has been developed for the solution-phase parallel synthesis of various drug-like 5-amino-substituted 1,2,4-thiadiazole derivatives, which employs initial cyclization reaction of carboxamidine dithiocarbamate 2 with p-toluenesulfonyl chloride. The carboxamidine dithiocarbamate 2 was produced by a three-component nucleophilic substitution reaction between carbon disulfide, benzamidine 1, and benzyl chloride. The key intermediate in this sequence, 5-(benzylsulfanyl)-3-phenyl-1,2,4-thiadiazole (3), is then transformed to the desired 5-amino-substituted 3-phenyl-1,2,4-thiadiazoles 6 in good yields and purities via oxidation of the sulfide group to form the corresponding sulfone followed by substitution reactions with various amines.
Key words
parallel synthesis - drug-like properties - 5-amino-1,2,4-thiadiazole - dithiocarbamate linker
-
1a
Krchňák V.Holladay MW. Chem. Rev. 2002, 102: 61 -
1b
Thompson LA.Ellman JA. Chem. Rev. 1996, 96: 555 -
1c
Terrett NK.Gardner M.Gordon DW.Kobylecki RJ.Steele J. Tetrahedron 1995, 51: 8135 -
2a
Pal M.Batchu VR.Parasuraman K.Yeleswarapu KR. J. Org. Chem. 2003, 68: 6806 -
2b
Watanabe N.Kabasawa Y.Takase Y.Matsukura M.Miyazaki K.Ishihara H.Kodama K.Adachi H. J. Med. Chem. 1998, 41: 3367 -
2c
Napoletano M.Norcini G.Pellacini F.Marchini F.Morazzoni G.Fattori F.Ferlenga P.Pradella L. Bioorg. Med. Chem. Lett. 2002, 12: 5 -
2d
Van der Mey M.Hatzelmann A.Van der Laan IJ.Sterk GJ.Thibaut U.Timmerman H. J. Med. Chem. 2001, 44: 2511 -
3a
Mullican MD.Wilson MW.Connor DT.Kostlan CR.Schrier DJ.Dyer RD. J. Med. Chem. 1993, 36: 1090 -
3b
Song Y.Connor DT.Sercel AD.Sorenson RJ.Doubleday R.Unangst PC.Roth BD.Beylin VG.Beylin VG.Gilbertsen RB.Chan K.Schrier DJ.Guglietta A.Bornemeier DA.Dyer RD. J. Med. Chem. 1999, 42: 1161 -
3c
Labanauskas L.Kalcas V.Udrenaite E.Gaidelis P.Brukstus A.Dauksas A. Pharmazie 2001, 56: 617 -
3d
Boschelli DH.Connor DT.Bornemeier DA.Dyer RD.Kennedy JA.Kuipers PJ.Okonkwo GC.Schrier DJ.Wright CD. J. Med. Chem. 1993, 36: 1802 -
4a
El-Emam AA.Al-Deeb OA.Al-Omar M.Lehmann J. Bioorg. Med. Chem. 2004, 12: 5107 -
4b
Dogan HN.Duran A.Rollas S.Sener G.Uysal MK.Gülen D. Bioorg. Med. Chem. 2002, 10: 2893 -
4c
Hollar BS.Gonsalves R.Shenoy S. Eur. J. Med. Chem. 2000, 35: 267 -
5a
Chapleo CB.Myers M.Myers PL.Saville JF.Smith ACB.Stillings MR.Tulloch IF.Walter DS.Welbourn AP. J. Med. Chem. 1986, 29: 2273 -
5b
Chapleo CB.Myers PL.Smith AC.Stillings MR.Tulloch IF.Walter DS. J. Med. Chem. 1988, 31: 7 -
5c
Akbarzadeh T.Tabatabai SA.Khoshnoud MJ.Shafaghi D.Shafiee A. Bioorg. Med. Chem. 2003, 11: 769 -
5d
Foroumadi A.Tabatabai SA.Gitinezhad G.Zarrindast MR.Shafiee A. Pharm. Pharmacol. Commun. 2000, 6: 1 -
6a
Turner S.Myers M.Gadie B.Nelson AJ.Pape R.Saville JF.Doxey JC.Berridge TL. J. Med. Chem. 1988, 31: 902 -
6b
Turner S.Myers M.Gadie B.Hale SA.Horsley A.Nelson AJ.Pape R.Saville JF.Doxey JC.Berridge TL. J. Med. Chem. 1988, 31: 907 -
6c
Tyagi M.Kumar A. Oriental J. Chem. 2002, 18: 125 -
7a
Yoo S.-e.Seo J.-s.Yi KY.Gong Y.-D. Tetrahedron Lett. 1997, 38: 1203 -
7b
Yoo S.-e.Gong Y.-D.Seo J.-s.Sung M.-M.Lee S.Kim Y. J. Comb. Chem. 1999, 1: 177 -
7c
Gong Y.-D.Yoo S.-e. Bull. Korean Chem. Soc. 2001, 21: 941 -
7d
Gong Y.-D.Seo J.-s.Chon Y.-S.Hwang J.-Y.Park J.-Y.Yoo S.-e. J. Comb. Chem. 2003, 5: 577 -
7e
Lee IY.Kim SY.Lee JY.Yu C.-M.Lee DH.Gong Y.-D. Tetrahedron Lett. 2004, 45: 9319 -
8a
Fawzi AB.Macdonald D.Bendow LL.Smith Torhan A.Zhang HT.Weig BC.Ho G.Tulshian D.Linder ME.Graziano MP. Mol. Pharmacol. 2001, 59: 30 -
8b
Lanzafame A.Christopoulos A. J. Pharmacol. Exp. Ther. 2004, 308: 830 -
8c
Castro A.Castano T.Encinas A.Porcal W.Gil C. Bioorg. Med. Chem. 2006, 14: 1644 -
9a
Mamaeva EA.Bakibaev AA. Tetrahedron 2003, 59: 7521 -
9b
Kihara Y.Kabashima S.Uno K.Furukawa M. Synthesis 1990, 1020 -
9c
Smith RF.Feltz TP. J. Heterocycl. Chem. 1981, 18: 201 -
10a
Kurzer F. Adv. Heterocycl. Chem. 1965, 5: 119 -
10b
Taliani L.Perronnet J. J. Heterocycl. Chem. 1979, 16: 961 - 11
Edward HK.Li D. Drug-like Properties: Concepts, Structure Design and Methods Academic Press; London: 2007. p.6-253 -
12a
Hwang JY.Choi H.-S.Lee D.-H.Yoo S.-e.Gong Y.-D. J. Comb. Chem. 2005, 7: 136 -
12b
Hwang JY.Choi H.-S.Lee D.-H.Yoo S.-e.Gong Y.-D. J. Comb. Chem. 2005, 7: 816 -
12c
Hwang JY.Gong Y.-D. J. Comb. Chem. 2006, 8: 297 -
14a
Oprea TI. J. Comput. Aided Mol. Des. 2000, 14: 251 -
14b
Veber DF.Johnson SR.Cheng H.-J.Smith BR.Ward KW.Kopple KD. J. Med. Chem. 2002, 45: 2615
References and Notes
Accord for Excel, Version 6.1, Synopsys Scientific Systems, Ltd., 5 North Hill Road, Headingley, Leeds, UK.